Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 5041 AL 5055

Intracortical surface-based MR diffusivity to investigate neurologic and psychiatric disorders: a review

Sampedro F, Kulisevsky J.

J Neuroimaging. 2022 Jan;32(1):28-35. doi: 10.1111/jon.12930. Epub 2021 Sep 10.

Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle

Chidambaram SB, Essa MM, Rathipriya AG, Bishir M, Ray B, Mahalakshmi AM, Tousif AH, Sakharkar MK, Kashyap RS, Friedland RP, Monaghan TM.

Pharmacol Ther. 2022 Mar;231:107988. doi: 10.1016/j.pharmthera.2021.107988. Epub 2021 Sep 16.

Apoptosis and its therapeutic implications in neurodegenerative diseases

Erekat NS.

Clin Anat. 2022 Jan;35(1):65-78. doi: 10.1002/ca.23792. Epub 2021 Oct 7.

Biological functions and potential therapeutic applications of huntingtin-associated protein 1: progress and prospects

Zhao X, Chen A, Wang Z, Xu XH, Tao Y.

Clin Transl Oncol. 2022 Feb;24(2):203-214. doi: 10.1007/s12094-021-02702-w. Epub 2021 Sep 26.

Juvenile-Onset Huntington Disease Pathophysiology and Neurodevelopment: A Review

Bakels HS, Roos RAC, van Roon-Mom WMC, de Bot ST.

Mov Disord. 2022 Jan;37(1):16-24. doi: 10.1002/mds.28823. Epub 2021 Oct 12.

Cognitive and social cognition deficits in Huntington's disease differ between the prodromal and the manifest stages of the condition: A scoping review of recent evidence

Cavallo M, Sergi A, Pagani M.

Br J Clin Psychol. 2022 Jun;61(2):214-241. doi: 10.1111/bjc.12337. Epub 2021 Oct 14.

Targeted protein degradation using intracellular antibodies and its application to neurodegenerative disease

Benn JA, Mukadam AS, McEwan WA.

Semin Cell Dev Biol. 2022 Jun;126:138-149. doi: 10.1016/j.semcdb.2021.09.012. Epub 2021 Oct 13.

Association between Serum Prolactin Levels and Neurodegenerative Diseases: Systematic Review and Meta-Analysis

Duc Nguyen H, Hoang NMH, Ko M, Seo D, Kim S, Jo WH, Bae JW, Kim MS.

Neuroimmunomodulation. 2022;29(2):85-96. doi: 10.1159/000519552. Epub 2021 Oct 20.

Protein clearance strategies for disease intervention

Hommen F, Bilican S, Vilchez D.

J Neural Transm (Vienna). 2022 Feb;129(2):141-172. doi: 10.1007/s00702-021-02431-y. Epub 2021 Oct 23.

Emerging Novel Approaches for the Enhanced Delivery of Natural Products for the Management of Neurodegenerative Diseases

Bandiwadekar A, Jose J, Khayatkashani M, Habtemariam S, Khayat Kashani HR, Nabavi SM.

J Mol Neurosci. 2022 Mar;72(3):653-676. doi: 10.1007/s12031-021-01922-7. Epub 2021 Oct 25.

Metabolism in Huntington's disease: a major contributor to pathology

Singh A, Agrawal N.

Metab Brain Dis. 2022 Aug;37(6):1757-1771. doi: 10.1007/s11011-021-00844-y. Epub 2021 Oct 27.

Insights of Extracellular Vesicles of Mesenchymal Stem Cells: a Prospective Cell-Free Regenerative Medicine for Neurodegenerative Disorders

Vatsa P, Negi R, Ansari UA, Khanna VK, Pant AB.

Mol Neurobiol. 2022 Jan;59(1):459-474. doi: 10.1007/s12035-021-02603-7. Epub 2021 Oct 29.

The emerging role of noncoding RNAs in neuroinflammation: Implications in pathogenesis and therapeutic approaches

Ebrahimi R, Golestani A.

J Cell Physiol. 2022 Feb;237(2):1206-1224. doi: 10.1002/jcp.30624. Epub 2021 Nov 1.

Multifaced role of protein deacetylase sirtuins in neurodegenerative disease

Gupta R, Ambasta RK, Kumar P.

Neurosci Biobehav Rev. 2022 Jan;132:976-997. doi: 10.1016/j.neubiorev.2021.10.047. Epub 2021 Nov 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias